Company Overview - The company is a global diversified pharmaceutical and medical devices entity serving over 70 markets [2] - It was founded in 1959, but the current configuration has been in place since 2015 due to significant acquisitions, including Salix Pharmaceutical and Bausch + Lomb [2] - The acquisitions have primarily been financed through debt, which is a relevant aspect of the company's financial story [2] Business Segments - The company operates in five different segments, including Bausch + Lomb [3] - Excluding Bausch + Lomb, the company has a strong presence in the U.S. pharmaceutical market through the Salix business and a diversified portfolio [3] - The International segment includes platforms in Europe, Latin America, and Canada, with a focus on Eastern European markets in Europe and a strong presence in Latin America [3]
Bausch Health Companies Inc. (BHC) Presents at Evercore 8th Annual Healthcare Conference Transcript